logo

Cytori Therapeutics Inc. (CYTX)



Trade CYTX now with
  Date
  Headline
11/24/2017 9:01:18 AM Cytori Says Rights Offering Oversubscribed By More Than 75%
11/20/2017 9:04:01 AM Cytori Reports Reduction In Fibrosis Parameters In Scar Study
11/16/2017 8:02:50 AM Cytori Announces Bioequivalence Trial Results In Ovarian Cancer At AAPS
8/10/2017 4:26:15 PM Cytori Therapeutics Q2 Loss/share $0.19 Vs. Loss $0.43 Year Ago
7/25/2017 4:32:57 PM Cytori Therapeutics Reports Inducement Grants For New Employees
7/24/2017 8:01:45 AM Cytori Announces Top-Line Results From STAR Trial Of Habeo Cell Therapy In Patients With Scleroderma
7/6/2017 7:01:06 AM Cytori Therapeutics Receives Key Cell Therapy Patent For Scleroderma
6/8/2017 7:06:36 AM Cytori Therapeutics Reports Publication Of Long-term Safety Data For Breast Reconstruction
6/1/2017 7:02:46 AM Cytori Therapeutics Plans To Introduce Its Next-generation Celution Technology
5/31/2017 9:04:57 AM Cytori Therapeutics, BARDA Execute $13.4 Mln Contract Option For Burn Clinical Trial
5/23/2017 8:32:12 AM Cytori Therapeutics Now Completes All 48 Week Follow Up Monitoring Visits In FDA Approved Phase III STAR Trial
5/11/2017 4:26:16 PM Cytori Q1 Adjusted Net Loss $5.9 Mln Or $0.26 Per Share